Testosterone replacement therapy in the era of telemedicine

Justin M. Dubin*, Richard J. Fantus, Joshua A. Halpern

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

The events of the 2019 SARS-CoV2 virus pandemic have all but ensured that telemedicine will remain an important aspect of patient care delivery. As health technologies evolve, so must physician practices. Currently, there is limited data on the management of testosterone replacement therapy (TRT) in the era of telemedicine. This review aims to explore the potential benefits and pitfalls of TRT management via telemedicine. We also propose a theoretical framework for TRT management via telemedicine. Telemedicine provides patients and physicians with a new mechanism for American Urological Association guideline-concordant TRT management that can increase patient access to care and provide a safe space for men who may otherwise not have been comfortable with in-person evaluation. However, there are significant limitations to the use of telemedicine for the management of TRT, including the inability to perform a physical exam, inability to administer specific medications, technological barriers, data security, and medical-legal considerations, and both patients and providers should engage in shared decision making before pursuing this approach. Understanding and acknowledging the potential pitfalls of telemedicine for TRT management will enable both patients and providers to achieve optimal outcomes and satisfaction.

Original languageEnglish (US)
JournalInternational Journal of Impotence Research
DOIs
StateAccepted/In press - 2021

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Testosterone replacement therapy in the era of telemedicine'. Together they form a unique fingerprint.

Cite this